Quinazolinone

Quinazolinone

SCHEMBL7744396

NN.O=c1nc[nH]c2ccccc12

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
PDPK1 O15530 1/20 0.46
CA12 O43570 1/20 0.46
ALOX15 P16050 1/20 0.46
CA9 Q16790 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
PRNP P04156 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
ATM Q13315 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinazolinone SCHEMBL10418 0.96 PARP1 (0.48) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL8201415 0.94 PARP1 (0.47) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL28241793 0.94 PARP1 (0.47) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL7746268 0.94 PARP1 (0.47) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL27387957 0.85 PBRM1 (0.42) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL27370560 0.85 PBRM1 (0.46) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL5266556 0.84 ALDH1A1 (0.42) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL27369780 0.83 SMN1; SMN2 (0.39) PARP1SMN1; SMN2PDPK1CA12ALOX15
Quinazolinone SCHEMBL28177707 0.77 CA12 (0.58) PARP1PDPK1CA12CA9CDK4
SCHEMBL8700858 0.73 PARP1 (0.54) PARP1SMN1; SMN2CA12CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6429311-B2 CHEMICAL INTERMEDIATE FOR HYPOTENSIVE AGENTS, BACTERICIDES, FUNGICIDES, ANTIPYRETICS AND ANTIDEPRESSANTS SEPRACOR INC. 2002-08-06 US disclosed
US-20010018518-A1 Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof GAO YUN (US) 2001-08-30 US disclosed
US-6184377-B1 ANTIPYRETIC, HYPOTENSIVE, ANTIBACTERIAL, ANTIFUNGAL OR CENTRAL NERVOUS SYSTEM (CNS) ACTIVITY, AS WELL AS THE ABILITY TO INHIBIT ENZYMES SEPRACOR INC. 2001-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018518-A1 Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof NQO2, ASNS, AAAS PARP1 2912/4885SMN1; SMN2 3617/4885PDPK1 3692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.